Search Results - "Salinas, Claudia Haydée Arce"

Capecitabine Plus Aromatase Inhibitor as First Line Therapy for Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer by Alvarado-Miranda, Alberto, Lara-Medina, Fernando Ulises, Muñoz-Montaño, Wendy R, Zinser-Sierra, Juan W, Galeana, Paula Anel Cabrera, Garza, Cynthia Villarreal, Sanchez Benitez, Daniel, Limón Rodríguez, Jesús Alberto, Arce Salinas, Claudia Haydee, Guijosa, Alberto, Arrieta, Oscar

“…(1) Background: recent evidence suggests that long low-dose capecitabine regimens have a synergistic effect with endocrine therapy as aromatase inhibitors…”
Get full text

Lymphoepithelioma-like carcinoma of breast: A case report and review of the literature by Nieto-Coronel, María, Perez-Sanchez, Víctor, Salazar-Campos, Jessica, Diaz-Molina, Raul, Arce-Salinas, Claudia

“…Lymphoepithelioma is a rare clinical entity, first was described in nasopharynx, and have been reported in another organs. Lymphoepithelioma-like carcinoma…”
Get full text

PO104 COMPARING EFFICACY AND TOXICITY IN HR+/HER2- METASTATIC BREAST CANCER PATIENTS TREATED WITH RIBOCICLIB OR PALBOCICLIB IN COMBINATION WITH ENDOCRINE THERAPY: RESULTS FROM A SINGLE CENTER IN MEXICO by Díaz, Andrea Maliachi, Padilla, Daniel Alejandro García, Hernández, Stefan Zilli, Salinas, Claudia Haydée Arce, Díaz, Diana Fabiola Flores, Santos, Juan Antonio Matus, Fernández, José Rodrigo Espinosa, Núñez, Carlos Arturo González, Reyes, Alexandra Garcilazo, Miranda, Alberto Alvarado, Medina, Fernando Ulises Lara, Martínez, Areli Velázquez, Agramonte, Luis André Salinas, Galicia, Julieta Santamaría, Galeana, Paula Anel Cabrera

Get full text

Abstract P4-03-32: Association between androgen receptor expression and recurrence free survival among locally advanced triple negative breast. Real world data from a single Institution in Mexico City by Alvarado, Eder Araiza, Salinas, Claudia Haydee Arce

“…Background The androgen receptor (AR) is expressed in 12-41% of the TNBC, contributes with differentiation, proliferation, apoptosis, and angiogenesis; its…”
Get full text

PO113 MORE IS BETTER? DOES EXTENDED TAXANE USE IN COMBINATION WITH TRASTUZUMAB IMPROVE OUTCOMES IN HER2-POSITIVE METASTATIC BREAST CANCER? by Reyes, Alexandra Garcilazo, Salinas, Claudia Haydee Arce, Suarez, Vanessa Leyva, Garcia, Elizabeth Garcia, Diaz, Diana Fabiola Flores, Fernández, José Rodrigo Espinosa, Medina, Fernando Ulises Lara, Medina, Alberto Alvarado, Santos, Juan Antonio Matus, Cruz, Sandy Ruiz, Nuñez, Carlos Arturo Gonzalez, Diaz, Andrea Maliachi, Villanueva, Sergio Aguilar, Galeana, Paula Anel Cabrera

Get full text

Correction: Alvarado-Miranda et al. Capecitabine Plus Aromatase Inhibitor as First Line Therapy for Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer. Curr. Oncol. 2023, 30, 6097–6110 by Alvarado-Miranda, Alberto, Lara-Medina, Fernando Ulises, Muñoz-Montaño, Wendy R., Zinser-Sierra, Juan W., Galeana, Paula Anel Cabrera, Garza, Cynthia Villarreal, Sanchez Benitez, Daniel, Limón Rodríguez, Jesús Alberto, Arce Salinas, Claudia Haydee, Guijosa, Alberto, Arrieta, Oscar

“…In the original publication [...]…”
Get full text

Abstract P6-05-36: Cost-effectiveness of CDK4/6 inhibitors as a First line Therapy for Metastatic Breast Cancer. A Mexican Cohort by Ramos-Ramírez, Maritza, Guzman-vazquez, Silvia, Dominguez-Esquivel, Vanessa, Espinosa-Fernandez, Jose Rodrigo, Ruiz-Cruz, Sandy, Cabrera-Galeana, Paula, Garcilazo, Alexandra, Cabrera-Miranda, Luis Antonio, Salinas, Claudia Haydee Arce

“…BACKGROUND. Breast cancer is the most frequent neoplasm worldwide, as reported by GLOBOCAN 2020, there were 2.2 million new cases per year and 680,000 deaths…”
Get full text

Satisfaction evaluation of medical attention at breast cancer service at National Cancer Institute Mexico by Ramirez-Morales, Rebeca, Santamaria-Galicia, Julieta, Aldama, Lucy, Bautista-Leon, Alejandra, Aguilar, Cristina, Alvarado Miranda, Alberto, Calderillo Ruiz, German, Arce Salinas, Haydee Claudia

“…Abstract only 156 Background: Breast cancer is the leading cause of attention at the INCan. In 2012, 44,761 medical consults were given therefore 19,584 (44%)…”
Get full text